Takeda Pharmaceutical Co. has offered to pay more than $2.2 billion to resolve claims of hiding its Actos diabetes medicine’s cancer risks in what would be one of the largest U.S. settlements of patient lawsuits targeting drugs or devices, three people familiar with the matter said.
Officials at Asia’s largest drugmaker propose to settle more than 8,000 lawsuits in federal and state courts in the U.S., said the people, who asked not to be identified because they weren’t authorized to speak publicly about the offer.
Help employers find you! Check out all the jobs and post your resume.
